Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
268.30
199.91
458.58
178.49
166.80
212.53
196.83
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
268.30
199.91
458.58
178.49
166.80
212.53
196.83
Raw Material Cost
40.84
29.72
24.87
14.07
34.81
40.86
34.01
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
10.32
10.85
11.28
11.15
11.05
11.53
12.53
Selling and Distribution Expenses
124.03
147.10
142.34
130.69
128.90
121.48
121.53
Other Expenses
6.66
6.34
5.69
5.59
7.54
6.48
7.60
Total Expenditure (Excl Depreciation)
241.83
251.06
235.40
211.78
250.12
238.69
244.11
Operating Profit (PBDIT) excl Other Income
26.5
-51.1
223.2
-33.3
-83.3
-26.200000000000003
-47.300000000000004
Other Income
3.00
3.35
4.41
2.75
2.49
1.63
2.96
Operating Profit (PBDIT)
29.76
-47.46
227.94
-30.09
-80.39
-24.09
-43.86
Interest
10.32
10.85
11.28
11.15
11.05
11.53
12.53
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
227.46
170.19
433.71
164.42
131.99
171.67
162.82
Depreciation
0.29
0.33
0.34
0.45
0.45
0.45
0.46
Profit Before Tax
19.15
-58.64
216.32
-41.69
-91.88
-36.07
-56.85
Tax
0.50
0.31
0.60
0.47
0.34
0.29
0.59
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
18.66
-58.95
215.72
-42.15
-92.22
-36.35
-57.45
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
18.66
-58.95
215.72
-42.15
-92.22
-36.35
-57.45
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
18.66
-58.95
215.72
-42.15
-92.22
-36.35
-57.45
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
414.92
370.15
401.17
156.31
164.22
228.54
237.12
Earnings per share (EPS)
0.14
-0.47
1.66
-0.33
-0.74
-0.29
-0.46
Diluted Earnings per share
0.14
-0.47
1.66
-0.33
-0.74
-0.29
-0.46
Operating Profit Margin (Excl OI)
9.86%
-25.58%
48.67%
-18.65%
-49.96%
-12.31%
-24.02%
Gross Profit Margin
7.25%
-29.17%
47.25%
-23.1%
-54.82%
-16.76%
-28.65%
PAT Margin
6.95%
-29.49%
47.04%
-23.61%
-55.29%
-17.11%
-29.19%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 60.85% vs -3.19% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 120.28% vs -38.86% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 132.33% vs -34.58% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -6.36% vs 57.14% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Apellis Pharmaceuticals, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
268.30
392.91
-124.61
-31.71%
Other Operating Income
0.00
0.00
0.00
Total Operating income
268.30
392.91
-124.61
-31.71%
Raw Material Cost
40.84
74.95
-34.11
-45.51%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
10.32
20.89
-10.57
-50.60%
Selling and Distribution Expenses
124.03
264.59
-140.56
-53.12%
Other Expenses
6.66
8.08
-1.42
-17.57%
Total Expenditure (Excl Depreciation)
241.83
441.19
-199.36
-45.19%
Operating Profit (PBDIT) excl Other Income
26.47
-48.28
74.75
154.83%
Other Income
3.00
7.25
-4.25
-58.62%
Operating Profit (PBDIT)
29.76
-21.61
51.37
237.71%
Interest
10.32
20.89
-10.57
-50.60%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
227.46
317.96
-90.50
-28.46%
Depreciation
0.29
19.43
-19.14
-98.51%
Profit Before Tax
19.15
-61.93
81.08
130.92%
Tax
0.50
4.55
-4.05
-89.01%
Provisions and contingencies
0
0
0.00
Profit After Tax
18.66
-66.48
85.14
128.07%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
18.66
-66.48
85.14
128.07%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
18.66
-66.48
85.14
128.07%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
414.92
1,751.53
-1,336.61
-76.31%
Earnings per share (EPS)
0.14
-0.40
0.54
135.00%
Diluted Earnings per share
0.14
-0.40
0.54
135.00%
Operating Profit Margin (Excl OI)
9.86%
-12.29%
0.00
22.15%
Gross Profit Margin
7.25%
-10.82%
0.00
18.07%
PAT Margin
6.95%
-16.92%
0.00
23.87%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 26.83 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 34.22% vs -56.41% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 60.85% vs -3.19% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.87 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 131.69% vs -127.35% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 120.28% vs -38.86% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.68 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 152.76% vs -122.73% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 132.33% vs -34.58% in Mar 2025
Quarterly - Interest
Interest 1.03 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -4.63% vs -4.42% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -6.36% vs 57.14% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.86%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
